Aspergillus bronchitis without significant immunocompromise

Annals of the New York Academy of Sciences

Volumn 1272, Issue 1, 2012, Pages 73-85

  Chrdle, Ales ^a,d   Mustakim, Sahlawati ^b   Bright Thomas, Rowland J ^a   Baxter, Caroline G ^a,c   Felton, Timothy ^a,c   Denning, David W ^a,c  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b Hospital Tengku Ampuan Rahimah   (Malaysia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Aspergillary; Bronchiectasis; Fumigatus; Mannose binding lectin; Niger; Precipitins

Indexed keywords

IMMUNOGLOBULIN G; PRECIPITIN;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS BRONCHITIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; BRONCHIECTASIS; BRONCHITIS; CLINICAL ARTICLE; COUGHING; DYSPNEA; FEMALE; FUNGUS CULTURE; HUMAN; MALE; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM;

EID: 84870889954     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06816.x     Document Type: Article

References (48)

1. Hope, W.W., T.J. Walsh & D.W. Denning 2005. The invasive and saprophytic syndromes due to Aspergillus spp. Med. Mycol. 43: 207-238.
2. Segal, B.H. 2009. Aspergillosis. N. Engl. J. Med. 360: 1870-1884.
3. Fedorova, N.D., N. Khaldi, V.S. Joardar, et al 2008. Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus. PLoS Genet. 4: e1000046.
4. Denning, D.W. 1995. Commentary: unusual manifestations of aspergillosis. Thorax 50: 812-813.
5. Kramer, M.R., D.W. Denning, S.E. Marshall, et al 1991. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am. Rev. Respir. Dis. 144: 552-556.
6. Mehrad, B., G. Paciocco, F.J. Martinez, et al 2001. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 119: 169-175.
7. Wu, N., Y. Huang, Q. Li, et al 2010. Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases. Clin. Microbiol. Infect. 16: 689-695.
8. Denning, D.W., S. Park, C. Lass-Florl, et al 2011. High frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52: 1123-1129.
9. Guinea, J., M. Torres-Narbona, P. Gijón, et al 2010. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin. Microbiol. Infect. 16: 870-877.
10. Fairs, A., J. Agbetile, B. Hargadon, et al 2010. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am. J. Respir. Crit. Care Med. 182: 1362-1368.
11. Wheaton, S.W. 1890. Case primarily of tubercle in which a fungus (aspergillus) grew in the bronchi and lung, simulating actinomycosis. Trans. Path. Soc. 41: 34-37.
12. Hoxie, G.H. & F.C. Lamar 1912. Fungous tracheobronchitis. JAMA 85: 95-96.
13. Lapham, M.E. 1926. Aspergillosis of the lungs and its association with tuberculosis. JAMA 87: 1031-1033.
14. Wahl, E.F. 1928. Primary pulmonary aspergillosis. JAMA 91: 200-202.
15. Castellani, A. 1928. Fungi and fungous diseases. Arch. Dermatol. Syphilis 17: 61.
16. Schneider, L.V. 1930. Primary aspergillosis of the lungs. Am. Rev. Tuberc. 22: 267-270.
17. Fawcitt, R. 1936. Fungoid conditions of the lungs-Part I. Br. J. Radiol. 9: 172-195.
18. Von Orstrand, H.S. 1940. Pulmonary aspergillosis. Cleveland Clin. Q. 7: 66-73.
19. Hinson, K.F.W., A.J. Moon & N.S. Plummer 1952. Broncho-pulmonary aspergillosis. A review and a report of eight new cases. Thorax 7: 317-333.
20. Riddell, R.W. & Y.M. Clayton 1958. Pulmonary mycoses occurring in Britain. Br. J. Tuberc. Dis. Chest 52: 34-44.
21. Symmers, W.S. 1962. Histopathologic aspects of the pathogenesis of some opportunistic fungal infections, as exemplified in the pathology of aspergillosis and the phycomycetoses. Lab. Invest. 11: 1073-1090.
22. Campbell, M.J. & Y.M. Clayton 1964. Bronchopulmonary aspergillosis. A correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis. Am. Rev. Respir. Dis. 89: 186-196.
23. Young, R.C., J.E. Bennett, C.L. Vogel, et al 1970. Aspergillosis. The spectrum of the disease in 98 patients. Medicine 49: 147-173.
24. Berlinger, N.T. & T.J. Freeman 1989. Acute airway obstruction due to necrotizing tracheobronchial aspergillosis in immunocompromised patients: a new clinical entity. Ann. Otol. Rhinol. Laryngol. 98: 718-720.
25. Denning, D.W., S. Follansbee, M. Scolaro, et al 1991. Pulmonary aspergillosis in AIDS. N. Engl. J. Med. 324: 654-662.
26. Kemper, C.A., J.S. Hostetler, S.E. Follansbee, et al 1993. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin. Infect. Dis. Sep. 17: 344-352.
27. Sambatakou, H. & D.W. Denning 2005. Invasive pulmonary aspergillosis transformed by immune reconstitution in AIDS into fatal mucous impaction. Eur. J. Clin. Microbiol. Infect. Dis. 24: 628-633.
28. Shoseyov, D., K.G. Brownlee, S.P. Conway & E. Kerem 2006. Aspergillus bronchitis in cystic fibrosis. Chest 130: 222-226.
29. Howard, S.J., A.C. Pasqualotto & D.W. Denning 2010. Azole resistance in ABPA and Aspergillus bronchitis. Clin. Microbiol. Infect. 16: 683-688.
30. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Updated 2010, © 2010 Global Initiative for Chronic Obstructive Lung Disease, Inc.
31. Hansell, D.M., A.A. Bamkier, H. MacMahon, et al 2008. Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 246: 697-722.
32. Bestall, J.C., E.A. Paul, R. Garrod, et al 1999. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54: 581-586.
33. Jain, L.R. & D.W. Denning 2006. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J. Infect. 52: e133-e137.
34. Standards Unit, Evaluations and Standards Laboratory, Centre for Infections. Investigation of bronchoalveolar lavage, sputum and associated specimens; BSOP57. Available at: http://www.hpa-standardmethods.org.uk/documents/bsop/pdf/bsop57.pdf. Accessed September 4, 2010.
35. Howard, S.J., D. Cerar, M.J. Anderson, et al 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15: 1068-1076.
36. Andes, D., A. Pascual & O. Marchetti 2009. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob. Agents Chemother. 53: 24-34.
37. Hope, WW, E.M. Billaud, J., Lestner & D.W. Denning 2008. Therapeutic drug monitoring for triazoles. Curr. Opin. Infect. Dis. 21: 580-586.
38. Harrison, E., A. Singh, N. Smith, et al 2012. Mannose binding lectin genotype and serum levels in patients with chronic or allergic pulmonary aspergillosis. Int. J. Immunogenetics 39: 224-232.
39. Lass-Flörl, C., G.M. Salzer, T. Schmid, et al 1999. Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients. Br. J. Haematol. 104: 745-747.
40. Lass-Flörl, C., S.A. Follett, A. Moody & D.W. Denning 2011. Detection of Aspergillus in lung and other tissue samples using the MycAssay™ Aspergillus real-time PCR kit. Can. J. Microbiol. 57: 765-768.
41. Baxter, C.G., A. Jones, A.K. Webb & D.W. Denning 2011. Homogenisation of cystic fibrosis sputum by sonication-an essential step for Aspergillus PCR. J. Microbiol. Method 85: 75-81.
42. Torelli, R., M. Sanguinetti, A. Moody, et al 2011. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J. Clin. Microbiol. 49: 4273-4278.
43. Schaffner, A., H. Douglas & A. Braude 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69: 617-631.
44. Ader, F. 2010. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. Curr. Infect. Dis. Rep. 12: 409-416.
45. Crim, C., P.M. Calverley, J.A. Anderson, et al 2009. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur. Respir. J. 34: 641-647.
46. Brown, G.D., D.W. Denning, N.A.R. Gow, et al Human fungal infections: the hidden killers. Sci. Transl. Med. In press.
47. Muhlebach, M.S., S.L. MacDonald, B. Button, et al 2006. Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent. Clin. Exp. Immunol. 145: 302-307.
48. Oguma, T., K. Asano, K. Tomomatsu, et al 2011. Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells. J. Immunol. 187: 999-1005.